Replies to post #2213 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Re: Decreased Bleeding Frequency With Secondary Prophylactic Use of NovoSeven

This is highly relevant to GTC. It’s clear that NovoSeven works as a prophylactic treatment for hemophiliacs with inhibitors, but it’s too darn expensive to be widely used in this setting. GTC and LFB hope to change that.